Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL (2020) Hansen BE, Jones D, Carbone M, Bowlus CL, Nevens F, Kremer A, Liberman A, et al. Conference contribution LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION (2020) Bowlus CL, Trauner MH, Kremer A, Liberman A, Malecha ES, Macconell L, Nevens F Conference contribution Editorial: Modulating Cytokines as Treatment for Autoimmune Diseases and Cancer (2020) Mortier E, Ma A, Malynn BA, Neurath M Journal article Towards shifted position-diffuse reflectance imaging of anatomically correctly scaled human microvasculature (2020) Späth M, Hohmann M, Roider C, Lengenfelder B, Stelzle F, Wirtz S, Klämpfl F Journal article Cyclic derivative of morphiceptin Dmt-cyclo-(D-Lys-Phe-D-Pro-Asp)-NH2(P-317), a mixed agonist of MOP and KOP opioid receptors, exerts anti-inflammatory and anti-tumor activity in colitis and colitis-associated colorectal cancer in mice (2020) Zielińska M, Szymaszkiewicz A, Jacenik D, Schodel L, Sałaga M, Zatorski H, Kordek R, et al. Journal article MULTICENTER ANALYSIS OF ENDOCLOT AS HEMOSTATIC POWDER IN DIFFERENT ENDOSCOPIC SETTINGS OF THE UPPER GASTROINTESTINAL TRACT (2020) Hagel A, Raithel M, Hempen P, Preclik G, Dauth W, Neurath M, Gschossmann J, et al. Journal article Cobitolimod for Moderate-to-Severe Left-Sided Ulcerative Colitis (CONDUCT): A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial (2020) Atreya R, Peyrin-Biroulet L, Klymenko A, Augustyn M, Bakulin I, Slankamenac D, Miheller P, et al. Conference contribution Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Conference contribution FLAMINGO SET FOR THE ENDOSCOPIC TREATMENT OF BURIED BUMPER SYNDROME: MULTICENTRE, RETROSPECTIVE, COHORT STUDY (2020) Costa D, Despott EJ, Woodward J, Kohout P, Rath T, Scovell L, Gee I, et al. Conference contribution FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity (2020) Hubbard JJ, Pyzik M, Rath T, Kozicky LK, Sand KMK, Gandhi AK, Grevys A, et al. Journal article